NCT06569498View on ClinicalTrials.gov

Neoadjuvant Triple Therapy for Resectable HCC

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

December 1, 2026

Conditions
Resectable Hepatocellular Carcinoma
Trial Locations (6)

350001

RECRUITING

Fujian provincial hospital, Fuzhou

350005

NOT_YET_RECRUITING

First Affiliated Hospital of Fujian Medical University, Fuzhou

350025

NOT_YET_RECRUITING

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

361005

NOT_YET_RECRUITING

Zhongshan Hospital of Xiamen University, Xiamen

361021

NOT_YET_RECRUITING

First Affiliated Hospital of Xiamen University, Xiamen

363099

NOT_YET_RECRUITING

Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou

All Listed Sponsors
lead

Fujian Provincial Hospital

OTHER